Keros Therapeutics
KROS
KROS
81 hedge funds and large institutions have $1.13B invested in Keros Therapeutics in 2020 Q4 according to their latest regulatory filings, with 36 funds opening new positions, 34 increasing their positions, 6 reducing their positions, and 4 closing their positions.
Holders
81
Holders Change
+32
Holders Change %
+65.31%
% of All Funds
1.44%
Holding in Top 10
4
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.07%
New
36
Increased
34
Reduced
6
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
Top Sellers
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
TRCT
76
Tower Research Capital (TRC)
New York
| $14K | 192 | -6,207 | -97% |
|
|
CSS
77
Cubist Systematic Strategies
Stamford,
Connecticut
| $14K | 200 | -707 | -78% |
|
|
ADIM
78
Alpha DNA Investment Management
Columbia,
Maryland
| $3K | 43 | +43 | New |
|
79
Daiwa Securities Group
Tokyo,
Japan
| $3K | 44 | +44 | New |
|
|
PAM
80
Panagora Asset Management
Boston,
Massachusetts
| $1K | 14 | +14 | New |
|
|
AIG
81
American International Group
New York
| $535 | 7,581 | +3,416 | +82% |
|
|
FI
82
Fosun International
Hong Kong,
China
| – | – | -83,545 | Closed |
|
|
TC
83
Telemus Capital
Southfield,
Michigan
| – | – | -15,000 | Closed |
|
|
PSC
84
Piper Sandler & Co
Minneapolis,
Minnesota
| – | – | -2,000 | Closed |
|
85
Nisa Investment Advisors
St. Louis,
Missouri
| – | – | -1,515 | Closed |
|
|
CFGS
86
Concourse Financial Group Securities
Birmingham,
Alabama
| – | – | – | – |
|